The Washington Post: How a cheap, generic drug became a darling of longevity enthusiasts

Barshop Institute director, Dr. Elena Volpi, was interviewed in a recent rapamycin article by The Washington Post.  The article also mentions the original 2009 rapamycin study funded by The National Institute on Aging Interventions Testing Program (ITP), which includes a test site at the Barshop Institute led by Dr. Randy Strong.

Read the story here: The Washington Post

Article Categories: News